Interleukin-1β Promoter Polymorphism Enhances the Risk of Sleep Disturbance in Alzheimer's Disease.
Sleep alleviates Alzheimer's disease (AD)-related neuropathological processes, whereas sleep disturbance in AD patients is associated with elevated peripheral inflammatory cytokine levels. In the present study, we assessed interleukin (IL)-1β and APOEε4 polymorphisms for association with suscep...
Main Authors: | You Yin, Yan Liu, Xiao Pan, Rui Chen, Peng Li, Hui-Juan Wu, Zheng-Qing Zhao, Yan-Peng Li, Liu-Qing Huang, Jian-Hua Zhuang, Zhong-Xin Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4777499?pdf=render |
Similar Items
-
Neuropeptide S: a new neuropeptide that regulates sleep and wake
by: Zheng-qing ZHAO, et al.
Published: (2013-05-01) -
Progress in studies of the reciprocal interaction between sleep disorders and Alzheimer's disease
by: Zhen-yu LIU, et al.
Published: (2013-06-01) -
Salvianolic acid B decreases interleukin-1β-induced colitis recurrence in mice
by: Pan-Pan Feng, et al.
Published: (2020-06-01) -
Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome
by: Shi-Wei Zhu, et al.
Published: (2019-07-01) -
Progress in study on central nervous system injuries caused by obstructive sleep apnea syndrome
by: Xiang-xiang ZHAO, et al.
Published: (2013-05-01)